Oscar Health, Inc. (OSCR) ended the recent trading session at $12.85, demonstrating a +0.16% swing from the preceding day's closing price. This change lagged the S&P 500's 1.08% gain on the day. Elsewhere, the Dow saw an upswing of 0.92%, while the tech-heavy Nasdaq appreciated by 1.41%.

The the stock of company has fallen by 19.05% in the past month, lagging the Finance sector's loss of 4.3% and the S&P 500's loss of 8.26%.

Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.83, reflecting a 33.87% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $2.8 billion, up 30.75% from the prior-year quarter.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.69 per share and revenue of $11.04 billion. These totals would mark changes of +590% and +20.34%, respectively, from last year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. currently has a Zacks Rank of #3 (Hold).

In terms of valuation, Oscar Health, Inc. is currently trading at a Forward P/E ratio of 18.59. This denotes a premium relative to the industry's average Forward P/E of 10.34.

The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 53, placing it within the top 22% of over 250 industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Oscar Health, Inc. (OSCR) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research